Sequence flexibility of the immunodominant HLA a*0201 restricted ppUL83 CD8 T-cell epitope of human cytomegalovirus

Journal of Medical Virology

Volumn 82, Issue 1, 2010, Pages 94-103

  Kopycinski, Jakub ^a   Osman, Mohamed ^a   Griffiths, Paul D ^a   Emery, Vincent C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Class I HLA; CTL escape; Mutations; Peptides; T cell receptor

Indexed keywords

CYSTEINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; HLA ANTIGEN CLASS 1; METHIONINE; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPROMISED PATIENT; MUTATION; NONHUMAN; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; VIRAL MATRIX PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 74849136149     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21668     Document Type: Article

References (34)

1. Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothé BR, Vogel TU, Dunphy E, LieblME, Emerson C, Wilson N, Kunstman KJ,WangX, Allison DB, Hughes AL, Desrosiers RC, Altman JD, Wolinsky SM, Sette A, Watkins DI. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407:386-390.
2. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379-385.
3. Baldanti F, Simoncini L, Sarasini A, Zavattoni M, Grossi P, Revello MG, Gerna G. 1998. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation 66:324-329.
4. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, Giuberti T, Fiaccadori F, Ferrari C. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180:933-943.
5. Boivin G, Gilbert C, Gaudreau A, Greenfield I, Sudlow R, Roberts NA. 2001. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J Infect Dis 184:1598-1602.
6. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, Shaw GM. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3:205-211.
7. Bowen EF, Emery VC, Wilson P, Johnson MA, Davey CC, Sabin CA, Farmer D, Griffiths PD. 1998. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS 12:605-611.
8. Chou S, Miner RC, Drew WL. 2000. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. J Infect Dis 182:1765-1768.
9. Chou S,Wechel LC, MarousekGI. 2007.CytomegalovirusUL97 kinase mutations that confer maribavir resistance. J Infect Dis 196:91-94.
10. Darlington J, Super M, Patel K, Grundy JE, Griffiths PD, Emery VC. 1991. Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J Gen Virol 72:1985-1989.
11. Emery VC, Griffiths PD. 2000. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci USA 97:8039-8044.
12. Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. 1999. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 190:177-182.
13. Engstrand M, Tournay C, Peyrat MA, Eriksson BM, Wadström J, Wirgart BZ, Romagné F, Bonneville M, Tötterman TH, Korsgren O. 2000. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 69:2243-2250.
14. Erice A, Gil-Roda C, Perez JL, Balfour HH, Jr., Sannerud KJ, Hanson MN, Boivin G, Chou S. 1997. Antiviral susceptibilities and analysis ofUL97 andDNApolymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis 175:1087-1092.
15. Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, Schuitemaker H, Goudsmit J, Pollakis G, Miedema F, Paxton WA, van Baarle D. 2006. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals. Virology 345:209-219.
16. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, TrochaA, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, Walker BD. 2001. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412:334-338.
17. Gratama JW, van Esser JW, Lamers CH, Tournay C, Löwenberg B, Bolhuis RL, Cornelissen JJ. 2001. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-celldepleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98:1358-1364.
18. Jones NA, Wei X, Flower DR, Wong M, Michor F, Saag MS, Hahn BH, Nowak MA, Shaw GM, Borrow P. 2004. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 200:1243-1256.
19. Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF. 2007. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS ONE 2:e225.
20. La Rosa C, Krishnan R, Markel S, Schneck JP, Houghten R, Pinilla C, Diamond DJ. 2001. Enhanced immune activity of cytotoxic Tlymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. Blood 97:1776-1786.
21. Lilley BN, Ploegh HL. 2005. Viral modulation of antigen presentation: Manipulation of cellular targets in the ER and beyond. Immunol Rev 207:126-144.
22. Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, Napoé G, Mothé BR, O'Connor DH, Wilson NA, Watkins DI, Sette A. 2004. Identification of seventeen new simian immunodeficiency virusderived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol 173:5064-5076.
23. Loh L, Batten CJ, Petravic J, Davenport MP, Kent SJ. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. J Virol 2007. 81:5418-5422.
24. Mocarski ES, Jr. 2004. Immune escape and exploitation strategies of cytomegaloviruses: Impact on and imitation of the major histocompatibility system. Cell Microbiol 6:707-717.
25. Nacsa J, Stanton J, Kunstman KJ, Tsai WP, WatkinsDI, Wolinsky SM, Franchini G. 2003. Emergence of cytotoxic T lymphocyte escape mutants following antiretroviral treatment suspension in rhesus macaques infected with SIVmac251. Virology 305:210-218.
26. Northfield J, Lucas M, Jones H, Young NT, Klenerman P. 2005. Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with "memory inflation" in human cytomegalovirus infection. Immunol Cell Biol 83:182-188.
27. Pillay T, Zhang HT, Drijfhout JW, Robinson N, Brown H, Khan M, Moodley J, Adhikari M, Pfafferott K, Feeney ME, St John A, Holmes EC, Coovadia HM, Klenerman P, Goulder PJ, Phillips RE. 2005. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J Virol 79:12100-12105.
28. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA. 2007. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 81:7759-7765.
29. RaeiszadehM, Kopycinski J, Paston SJ, Diss T, Lowdell M, Hardy GA, Hislop AD, Workman S,Dodi A, Emery V, Webster AD. 2006. The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin Exp Immunol 146:234-242.
30. Roy DM, Grundy JE, Emery VC. 1993. Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: Comparison of isolates from renal transplant recipients and AIDS patients. J Gen Virol 74:2499-2505.
31. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ. 2005. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673-685.
32. Weekes MP, Wills MR, Mynard K, Carmichael AJ, Sissons JG. 1999. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol 73:2099-2108.
33. Whalley SA, Brown D, Webster GJ, Jacobs R, Reignat S, Bertoletti A, Teo CG, Emery V, Dusheiko GM. 2004. Evolution of hepatitis B virus during primary infection in humans: Transient generation of cytotoxic T-cell mutants. Gastroenterology 127:1131-1138.
34. Zaia JA, Gallez-Hawkins G, Li X, Yao ZQ, Lomeli N, Molinder K, La Rosa C, Diamond DJ. 2001. Infrequent occurrence of natural mutations in the pp65(495-503) epitope sequence presented by the HLA A*0201 allele among human cytomegalovirus isolates. J Virol 75:2472-2474.